Qiming entities (NASDAQ: ALMR) disclose sizable preferred stakes in Alamar Biosciences
Rhea-AI Filing Summary
Alamar Biosciences, Inc. received an initial Form 3 from several Qiming-affiliated investment vehicles reporting indirect ownership of multiple series of preferred stock. These preferred shares are convertible into Class B Common Stock and will automatically convert into common stock upon the closing of the company’s initial public offering pursuant to their terms.
The filing shows holdings of Series A-3, Series A-4, Series B and Series C Preferred Stock, all with a stated conversion feature and no expiration date. Qiming Corporate GP VI, Ltd., Qiming GP VIII, LLC and Qiming GP VIII-HC, LLC may be deemed to have voting and dispositive power over certain positions but each disclaims beneficial ownership beyond its proportionate pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Series A-3 Preferred Stock | -- | -- | -- |
| holding | Series A-3 Preferred Stock | -- | -- | -- |
| holding | Series A-4 Preferred Stock | -- | -- | -- |
| holding | Series A-4 Preferred Stock | -- | -- | -- |
| holding | Series B Preferred Stock | -- | -- | -- |
| holding | Series B Preferred Stock | -- | -- | -- |
| holding | Series C Preferred Stock | -- | -- | -- |
| holding | Series C Preferred Stock | -- | -- | -- |
Footnotes (1)
- Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock is convertible into 0.4136 share of Class B Common Stock, at the holder's election, and will automatically convert into shares of the Issuer's common stock upon the closing of the initial public offering pursuant to their terms. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock have no expiration date. These shares are held of record by Qiming Managing Directors Fund VI, L.P. ("Qiming Managing Directors"). Qiming Corporate GP VI, Ltd. ("Qiming Corporate") serves as the general partner of Qiming Managing Directors and may be deemed to have voting and dispositive power over the shares held by Qiming Managing Directors. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. These shares are held of record by Qiming Venture Partners VI, L.P., ("Qiming Venture Partners VI"). Qiming Corporate, through one intermediary, serves as the indirect general partner of Qiming Venture Partners VI and may be deemed to have voting and dispositive power over the shares held by Qiming Venture Partners VI. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. Each share of Series B Preferred Stock is convertible into 0.4403 share of Class B Common Stock, at the holder's election, and will automatically convert into shares of the Issuer's common stock upon the closing of the initial public offering pursuant to their terms. The Series B Preferred Stock has no expiration date. These shares are held of record by Qiming Venture Partners VIII Investments, LLC ("QVP VIII LLC"). Qiming GP VIII, LLC, through two parallel intermediaries, serves as the indirect general partner of QVP VIII LLC and may be deemed to have voting and dispositive power over the shares held by QVP VIII LLC. Qiming GP VIII, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. These shares are held of record by Qiming Venture Partners VIII-HC, L.P. ("QVP VIII-HC"). Qiming GP VIII-HC, LLC serves as the general partner of QVP VIII-HC and may be deemed to have voting and dispositive power over the shares held by QVP VIII-HC. Qiming GP VIII-HC, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.